Description:

The company is an ISO-certified scientific & management consulting firm specialized in solving technical and regulatory issues, as well as overall management consulting, for federal government agencies and private government contractors. The company’s consulting services are primarily life sciences-based, providing solutions such as pharmaceutical production quality assurance, research & development support, medical logistics, and overall program management.

Key Aspects:

Revenue and adjusted EBITDA have grown at compound annual growth rates (CAGRs) of 18.9% and 40.3%, respectively, from 2020 to the trailing-twelve-months (TTM) ending March 31, 2023
Average adjusted EBITDA margin of 21.2% from 2020 to 2022
Remaining amount to be billed on open contracts totaled $19,811,383 as of March 31, 2023
Diverse catalog of service offerings, with no single segment accounting for more than 36.1% of revenue, as of 2022
History of collaborative development with key federal agencies on new service initiatives, yielding a strong reputation in the industry and high client retention rate
Skilled team of consultants and subject-matter-experts (SMEs), enabling the company to provide consistent, high-quality advisory services
As of 2023, all of the company’s contracts have either women-owned designations or small-business designations, which together represent 100% of revenue

Opportunities:

Complete the introduction of the company’s newest service line, and further develop this service with global potential to focus on later-stage business process consulting.
Capitalize on the company’s trusted affiliations with many key federal agencies, yielding a steady stream of new projects and engagement with numerous high-growth clients.
Leverage the company’s existing client base to fully transition into a ‘Clinical Research Organization’ model.
Capitalize on the company’s current reputation among private pharmaceutical companies, yielding a greater amount of new projects and allowing the development of specific services for non-government contracts.

Headquartered:

Mid-Atlantic, US

Current Markets:

The company primarily serves federal government agencies and private government contractors with a focus on the federal life-sciences sector, in addition to federal financial services and private pharmaceutical companies.

Real Estate:

The company operates from a 1,500 sq. ft. office space leased from an unrelated third party. There is room to grow in the current location.

Shareholder Ownership:

The company is fully owned by a single shareholder who would like to de-risk and start preparing for retirement. To facilitate a smooth transition of ownership, the current shareholder is willing to remain with the company for a predetermined amount of time, or for a longer period of time under a new position, depending on the wishes of new ownership.

Benchmark International

Benchmarks Exclusive Opportunities

Management Consulting Firm – BN000032243

Management Consulting Firm – BN000032243

Login